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Abstract
Objective To determine the frequency and consequences of intra- and postoperative adverse events in awake craniotomy for
intrinsic supratentorial brain tumors. Despite the growing prevalence of awake craniotomy intra- and postoperative, adverse
events related to this surgery are poorly discussed.
Methods We studied 25 patients undergoing awake craniotomy with maximum safe resection of intrinsic supratentorial brain
tumors in the awake-asleep-awake protocol.
Results Surgery-related inconveniences occurred in 23 patients (92%), while postoperative adverse events were observed in 17
cases (68%). Seven patients suffered from more than one postoperative complication. The most common surgery-related
inconvenience was intraoperative hypertension (8 cases, 32%), followed by discomfort (7 cases, 28%), pain during surgery (5
cases, 20%), and tachycardia (3 cases, 12%). The most common postoperative adverse event was a new language deficit that
occurred in 10 cases (40%) and remained permanent in one case (4%). Motor deficits occurred in 36% of cases and were
permanent in one case (1%). Seizures were observed in 4 cases (16%) intra- and in 2 cases (8%) postoperatively. Seizures
appeared more frequently in patients with multilobar insular-involving gliomas and in patients without prophylactic antiepileptic
drug therapy.
Conclusions Surgery-related inconveniences and postoperative adverse events occur in most awake craniotomies. The most
common intraoperative adverse event is hypertension, pain, and tachycardia. The most frequent postoperative adverse events
are new language deficits and new motor deficits.
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Introduction
Awake craniotomy (AC) with cortical and subcortical brain
mapping has become a standard method in the treatment of
intrinsic brain tumors located in eloquent brain areas [1].
There is a growing body of evidence that awake craniotomy
is an effective method for treatment of gliomas promoting a
higher extent of resection, a lower incidence of neurological
complications, and ensuring better overall survival while deal-
ing with language and motor locations [2, 3]. Awake surgery
is gaining attention in the field of other intracranial patholo-
gies such as aneurysm repair, arteriovenous malformation ex-
cisions [4], and metastasis surgery [5]. When compared with
surgery under general anesthesia, awake craniotomy for elo-
quent brain tumors ensures better onco-functional balance [6].
Despite wide discussion on the effectiveness of the awake
craniotomy procedure, related complications are often
neglected. Usually authors limit the presentation of complica-
tions to a superficial description of the outcome and basic
deficits that occurred [7]. Therefore there is a need for identi-
fication of intra- and postoperative complications of awake
surgery. The intra and postoperative complications may be
related to surgical and anesthesiological factors. The most
common surgical complications are: seizures and new neuro-
logical deficits. Complications related to anesthesia care like
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desaturation often lead to AC failure with a need for conver-
sion to general anesthesia [8].
In the present study, we sought to determine the most com-
mon surgery and anesthesia care–related inconveniences and
postoperative adverse events in patients undergoing AC for
intrinsic brain tumors in eloquent brain locations and establish
their frequency.
Materials and Methods
We retrospectively analyzed the data of 25 patients who
underwent maximum safe resection for intrinsic supratentorial
brain tumors in an asleep-awake-asleep (SAS) setting between
2014 and 2017 in one neurosurgical center. The indication for
awake craniotomy was a tumor located in an eloquent brain
area. Patients with a substantial neurological deficit prior to
surgery were not qualified for awake craniotomy. Substantial
deficit was understood as a lack of ability to cooperate during
the awake procedure or motor weakness greater than 3/5 ac-
cording to the Lovett scale. We studied the detailed medical
history, including chronic diseases and medication taken. All
patients were assessed according to the American Society of
Anaesthesiologists (ASA) Physical Status Classification
System. All patients underwent neuropsychological evalua-
tion and testing pre-, intra-, and postoperatively.
The asleep phase was achieved using the total intravenous
anesthesia protocol (propofol and remifentanil) and the air-
ways were secured with a laryngeal mask (i-gel®). The mon-
itoring of the following parameters was performed throughout
the procedure: mean arterial blood pressure, heart rate, end-
tidal CO2 concentration (during the asleep phase, when the
laryngeal mask was inserted), percentage of oxygenated he-
moglobin, and temperature.
All patients were treated with a tailored craniotomy, large
enough to perform positive brain mapping followed by the
maximum safe resection of the tumor during the awake phase.
Positive brain mapping was defined as cortical or subcortical
current stimulation which provokes a temporary onset of neu-
rological symptoms in awake patients, like speech arrest or
motor weakness. The maximum safe resection was defined
as the maximal possible tumor resection without inducing
new neurological deficit and while controlled by intraopera-
tive brain mapping techniques. Intraoperative seizures were
managed with ice cold Ringer’s lactate. After tumor resection,
during the wound closing procedure, mild sedation with
remifentanil and propofol were used as well as pain control
medications.
Surgery and anesthesia care–related inconveniences and
postoperative adverse events were analyzed. Hypertension
was defined as systolic blood pressure over 140 mmHg and
diastolic over 90 mmHg. Hypotension was defined as systolic
blood pressure under 90 mmHg and diastolic under 60
mmHg. Tachycardia was recognized when the heart rate
exceeded 100 beats per minute, bradycardia when the heart
rate was below 60 beats per minute. Desaturation was defined
as SpO2 < 90%. Brain edema was reported by the operating
surgeon if the brain exceeded the outer table of the craniotomy
window. Nausea was recorded as reported by patients.
Seizures and vomiting were recorded if they occurred during
surgery. New neurological deficits (language or motor) were
considered a new finding if present during the neurological
examination directly after surgery. A transient deficit was rec-
ognized if this subsided within 30 days of surgery. A neuro-
logical deficit was defined as permanent if it was present after
a 30-day follow-up. The postoperative period was defined as
the first 30 days after surgery. The extent of resection based on
control MR imaging was analyzed. All patients received an
MRI three to six months postoperatively. The extent of resec-
tion was evaluated based on fluid-attenuated inversion recov-
ery MRI sections.
Written consent was obtained from all patients involved
into the study upon admission to the hospital. This study
was conducted in accordance with the ethical standards laid
down in the Declaration of Helsinki (1964) and its design was
approved by the local University Bioethical Committee (pro-
tocol number 1072.6120.305.2018).
We used elements of descriptive statistics including mean,
standard deviation, and percentage value to analyze our data.
Results
The study group consisted of 25 patients (8 female, 32%).
Mean age was 47.96 ± 15.97 years. The patients’ preoperative
ASA scores were no worse than 3. The patients’ as well as
their tumors’ characteristics are shown in Table 1. Among the
patients, 17 diffused astrocytomas (68%), 4 anaplastic astro-
cytomas (16%), and 4 glioblastomas (16%) were diagnosed.
Gross total resection was performed in 20 cases (80%). In 5
cases (20%), subtotal resection was achieved. All cases with a
tumor diameter ≥ 5 cm preoperatively received subtotal
resection.
Surgery-related inconveniences and postoperative adverse
events occurred in 23 cases (92%) and are presented in
Table 2. The most frequent intraoperative event was hyperten-
sion, which occurred in 8 cases (32%). Pain was present in 5
cases (20%) and tachycardia occurred in 3 cases (12%).
Postoperative adverse events were noticed in 17 cases
(68%). All patients suffered from more than one adverse
event. Hypertension was present in five cases during the
awake phase. All cases with pain or psychological stress
coexisted with hypertension. Two cases of tachycardia
were linked with pain, one with psychological stress.
New language deficit was the most frequent postoperative
adverse event and occurred in 10 cases (40%); it turned
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out to be permanent in one case (4%). The second most
frequent was new motor deficit, which occurred in 9 cases
(36%) and was permanent in one case (4%). Seizures
were observed in 4 cases (16%) intra- and in 2 cases
(8%) postoperatively. Seizures appeared more frequently
in patients with multilobar insular-involving gliomas (4
patients, 16% of the study group and 66.66% of cases
with treatment related seizures) and in patients without
prophylactic antiepileptic drugs (5 patients, 20% of the
study group and 83.33% of cases with treatment related
seizures). One patient (4%) with an intraoperative seizure
presented with desaturation and this resulted in eventual
conversion to general anesthesia. All cases that presented
with intraoperative seizures reported seizures prior to sur-
gery. The incidence and occurrence of seizures are pre-
sented in Table 3. One patient, after a large multilobar
tumor (diameter over 5 cm) resection, required decom-
pressive craniectomy. The patient deteriorated within the
first postoperative day (seizures, decreased consciousness
level, hemiparesis). Control head CT revealed a brain ede-
ma and hemorrhagic progression. After emergency reop-
eration the patient recovered completely during the post-
operative period. All seizure episodes as well as hemor-
rhagic complications occurred after large tumor (diameter
over 5 cm) removal. Neither infections nor wound healing
problems were observed in the study group.
Discussion
We analyzed the adverse events observed during and after
awake craniotomy for intrinsic brain tumors according to our
own experience.
We found the most frequent intraprocedural adverse event
was hypertension. The adverse events registered most com-
monly after surgery were new language and motor deficits.
More than 90% of the new deficits subsided within the post-
operative period. Hypertension is rarely reported in awake
Table 1 Patients’ characteristics including location and histopathology
of gliomas
Characteristic Patients %
Age ± standard deviation 47.96 ± 15.87
History of the patients
Headache 21 84
First, single epileptic attack 12 48
More than one epileptic seizure 6 24
Numbness 8 32
Motor deficit 4 16
Smoking 6 24
Regular alcohol intake 1 4
Obesity 4 16










ASA I class 12 48
ASA II class 11 44
ASA III class 2 8
Tumor grade
WHO II 17 68
WHO III 4 16
WHO IV 4 16
Location in the left hemisphere
Frontal lobe 6 24
Temporal lobe 7 28
Parietal lobe 1 4
Multilobar insula involving 10 40
Tumor size
≥ 5 cm 19 76
< 5 cm 6 24
Table 2 Intra- and postoperative adverse events
Intraoperative adverse event Number of patients %
Arterial hypertension 8 32
Discomfort during surgery 7 28
Pain during surgery 5 20
Intraoperative seizures 4 16
Tachycardia 3 12
Psychological stress 3 12
Arterial hypotension 2 8
Bradycardia 1 4
Desaturation 1 4
Brain swelling 1 4
Nausea/vomiting 1 4
Aborted-converted to sleep 1 4
Postoperative adverse event
New language deficit 10 40
New motor deficit 9 36
Postoperative seizures 2 8
Postoperative nausea/vomiting 2 8
Decreased conscious level 1 4
Permanent language deficit 1 4
Permanent motor deficit 1 4
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craniotomy. Eseonu et al. reported hypertension being the
most common complication of awake surgery [9] but limited
data regarding its causality are available. Hypertension during
awake surgery corresponds with pain or psychological stress
and their overlapping. This thesis may be supported by the
higher incidence of intraoperative hypertension in patients un-
dergoing surgery under conscious sedation when compared
with asleep-awake-asleep surgery [10]. In our setting, all pa-
tients underwent the asleep-awake procedure, to reduce poten-
tial stress related to the craniotomy procedure. Higher comfort
and pain reduction are reported by other studies to be advan-
tages of the asleep-awake-asleep procedure [10, 11].
Seizures leading in some cases to transient neurological
deterioration were potentially serious complications. The use
of prophylactic antiepileptic drugs for brain tumors in patients
undergoing craniotomy remains controversial [12, 13], even
in patients operated in an awake setting [14–16].
Conclusions
With this paper, we would like to stress the need for analysis
and prevention of adverse events during and after awake sur-
gery for brain tumors. The need for reduction in the patient’s
stress and pain is the first conclusion which can be drawn from
our results. As seizures are a typical adverse event for gliomas
and can be easily induced by brain stimulation intraoperative-
ly or brain irritation after surgery, the use of prophylactic
anticonvulsants seems to be the proper option while dealing
with a patient treated with awake craniotomy.
The removal of large tumors is more prone to produce
intraoperative seizures and these patients are at a higher risk
of postoperative hemorrhage, according to our observation.
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